Serum von Willebrand factor levels in patients with inflammatory bowel disease are related to systemic inflammation

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 3, 1999, Pages 287-290

  Meucci, G ^a   Pareti, F ^a   Vecchi, Maurizio ^a,b   Saibeni, S ^a   Bressi, C ^a   De Franchis, R ^a  

^a Institute of Internal Medicine   (Italy)

^b Istituto di Medicina Interna   (Italy)

Author keywords

Crohn disease; Endothelial injury; Inflammation; Inflammatory bowel disease; Ulcerative colitis; Von Willebrand factor

Indexed keywords

ACUTE PHASE PROTEIN; OROSOMUCOID; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; ULCERATIVE COLITIS;

EID: 0032907925     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529950173708     Document Type: Article

References (15)

1. 1. Blann AD. Von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J Rheumatol 1993;20:1469-71.
2. 2. Gris JC, Schved JF, Raffanel C, Dubois A, Aguilar-Martinez P, Arnaud A, et al. Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Thromb Haemost 1990;63:472-5.
3. 3. Stevens TRJ, James JP, Simmonds NJ, McCarthy DAM, Laurenson IF, Maddison PJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut 1992;33:502-6.
4. 4. Stevens TRJ, Harley SL, Groom JS, Cambridge G, Leaker B, Blake DR, et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 1993;38:426-32.
5. 5. Sawyerr AM, Smith MS, Hall A, Hudson M, Hay CR, Wakefield AJ, et al. Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of the endothelial function in inflammatory bowel disease. Dig Dis Sci 1995;40: 793-9.
6. 6. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzales D, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40:1883-9.
7. 7. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles OM, Lewis AAM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057-62.
8. 8. Hamilton M, Dick R, Crawford L, Thompson N, Pounder R, Wakefield A. Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet 1995;345:688-90.
9. 9. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson GD. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989;5:387-94.
10. 10. Rachmilewitz D. Coated mesalamine (5-aminosalicylic acid) versus ± sulphasalazine in the treatment of active ulcerative colitis; a randomised trial. Br Med J 1989;298:82-6.
11. 11. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's disease study. Gastroenterology 1976;70:439-44.
12. 12. Lattuada A, Mannucci PM, Chen C, Legnani C, Palareti G. Transfusion requirements are correlated with the degree of proteolysis of von Willebrand factor during orthotopic liver transplantation. Thromb Haemost 1997;78:813-9.
13. 13. Saverymuttu SH, Hodgson UJF, Chadwick VS, Peyps MB. Differing acute phase responses in Crohn's disease and ulcerative colitis. Gut 1986;27:809-13.
14. 14. Brignola C, Iannone P, Belloli C, De Simone G, Bassein L, Gionchetti P, et al. Prediction of relapse in patients with Crohn's disease in remission: a simplified index using laboratory tests, enhanced by clinical characteristics. Eur J Gastroenterol Hepatol 1994;6:955-61.
15. 15. van der Poll T, van Deventer SJH, Paster Kamp G, van Mourik JA, Buller HR, ten Cate JW. Tumor necrosis factor induces von Willebrand factor relaease in healthy humans. Thromb Haemost 1992;67:623-6.